In this article, we are going to take a look at where NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) stands against the other psychedelic stocks. In contrast to drugs like cocaine or marijuana ...
NRx Pharmaceuticals NRXP is expected to report its fourth-quarter 2024 results soon. The Zacks Consensus Estimate for NRXP’s loss per share is pinned at 20 cents. In the absence of a marketed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback